Henry Scott Quotations

We have scout teams who go out and ID where the birds are. And when we find birds using a field, we'll hunt that field.

Underground facilities do have a certain amount of negative aspect to them.

There are the friends that understand, and the friends that don't. The friends who don't have truly never had the full experience of post-secondary education. I always found that if you tie yourself down to just the two, work and school, you aren't as productive as you'd like to be. You need to have fun.

I think this could be a $1 billion-a-year-drug and is the kind of product Pfizer needs.

People just extrapolate off the last data point.

We have a lot of quail here, and we're going to have quail hunting this fall. It's not uncommon to flush 35 to 40 coveys a day.

The question is how large is that market.

Why bother with Merck? How many venues can they (Merck) really concentrate on?

We expected higher research and development costs, but the revenues were also on the weak side.

This approval takes some risk out of the equation for them. If they can get the production capacity, it has the potential to be a significant drug. The big issue for Bristol is patent expirations and whether the pipeline can offset them.

A big wildcard is how much capacity do these guys have.

It's the best possible win for the case, but it is not the end of the battle. The next test case will really be long-term users. Investor sentiment certainly swings probably more than it should on each individual case.

It was mediocre. I thought we'd see more, but they flew fairly well. We'll get on a better field this afternoon.

I still believe Pfizer will win the U.S. case, but you can never make any assumptions in a patent dispute.

Investors will look at the quarter and like fact that they beat estimates.